| Structure | Chemical Name | CAS | MF |
|
4-Pyridinecarboperoxoicacid(9CI)
|
121343-59-7
|
C6H5NO3
|
|
3-Pyridinecarboperoxoicacid(9CI)
|
121343-63-3
|
C6H5NO3
|
|
3-Pyridinecarboxylicacid,6-(fluoromethyl)-(9CI)
|
121343-80-4
|
C7H6FNO2
|
|
Fmoc-L-glutamic acid
|
121343-82-6
|
C20H19NO6
|
|
2(3H)-Benzothiazolone,dimethylhydrazone(9CI)
|
121343-91-7
|
C9H11N3S
|
|
3-(Diethylamino)-5a,6-dihydro-7-oxo-7H-[1]benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile
|
121344-18-1
|
C23H20N4O2
|
|
3,4-DIMETHOXY-N-METHYL-N-[3-[4-[[1-METHYL-3-(1-METHYLETHYL)-1H-INDOL-2-YL]SULFONYL]PHENOXY]PROPYL]BENZENEETHANAMINE OXALATE
|
121346-32-5
|
C32H40N2O5S
|
|
1-(2,5-Dimethoxyphenyl)-2-oximino-1-propanone
|
121347-31-7
|
C11H13NO4
|
|
5-ACETYL-6-METHYL-2-MORPHOLINONICOTINONITRILE
|
121348-09-2
|
C13H15N3O2
|
|
5-ACETYL-6-METHYL-2-PIPERIDINONICOTINONITRILE
|
121348-11-6
|
C14H17N3O
|
|
5-ACETYL-6-METHYL-2-(1-PYRROLIDINYL)NICOTINONITRILE
|
121348-12-7
|
C13H15N3O
|
|
5-ACETYL-6-METHYL-2-(METHYLAMINO)NICOTINONITRILE
|
121348-13-8
|
C10H11N3O
|
|
5-ACETYL-2-CHLORO-6-METHYLNICOTINONITRILE
|
121348-15-0
|
C9H7ClN2O
|
|
3-Pyridinecarbonitrile, 5-acetyl-6-methyl- (9CI)
|
121348-16-1
|
C9H8N2O
|
|
Cyanamide, (1-methyl-2-pyrrolidinylidene)- (9CI)
|
121348-58-1
|
C6H9N3
|
|
1-O-benzyl-2-O-methylglycerol
|
121348-74-1
|
C11H16O3
|
|
helicascolide A
|
121350-98-9
|
C12H20O3
|
|
Fluorodaunorubicine
|
121351-02-8
|
C27H28FNO10
|
|
D-Mannonic acid, 3,6-anhydro-, gamma-lactone (9CI)
|
121351-12-0
|
C6H8O5
|
|
3',3'-difluoro-3'-deoxythymidine
|
121353-87-5
|
|
|
2,4(1H,3H)-Pyrimidinedione, 1-[2-deoxy-2-fluoro-5-O-[(4-methoxyphenyl)diphenylmethyl]-β-D-arabinofuranosyl]-5-methyl-
|
121353-88-6
|
C30H29FN2O6
|
|
1-(2-Fluoro-2,3-dideoxy-β-D-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
|
121353-89-7
|
C10H13FN2O4
|
|
2-Propenoic acid, polymer with butyl 2-propenoate, ethyl 2-propenoate, N-(hydroxymethyl)-2-propenamide and methyl 2-propenoate
|
121355-39-3
|
C23H37NO10
|
|
(1'-NAPHTHYL) 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
|
121356-12-5
|
C24H27NO9
|
|
3-Butyn-1-ol, 4-(2-pyrimidinyl)- (9CI)
|
121356-77-2
|
C8H8N2O
|
|
2-Pyrimidinehexanol (9CI)
|
121356-80-7
|
C10H16N2O
|
|
2-Propyn-1-ol, 3-(2-thiazolyl)- (9CI)
|
121356-98-7
|
C6H5NOS
|
|
2-(2-METHYL-1,3-THIAZOL-4-YL)ETHANOL 97+%
|
121357-04-8
|
C6H9NOS
|
|
2-Carbamyl-9-[beta-d-ribofuranosyl]hypoxanthine
|
121358-21-2
|
|
|
4-Bromo-1-(phenylsulfonyl)pyrazole
|
121358-73-4
|
C9H7BrN2O2S
|
|
1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE
|
121358-86-9
|
C11H9N3
|
|
2-(TRIBUTYLSTANNYL)THIAZOLE
|
121359-48-6
|
C15H29NSSn
|
|
6H-Pyrazino[1,2-c]pyrimidin-6-one,7-ethyloctahydro-,(+)-(9CI)
|
121360-21-2
|
C9H17N3O
|
|
6H-Pyrazino[1,2-c]pyrimidin-6-one,7-ethyloctahydro-,(-)-(9CI)
|
121360-22-3
|
C9H17N3O
|
|
Nitrous acid, 1-methyl-3-oxobutyl ester (9CI)
|
121361-50-0
|
C5H9NO3
|
|
β-Acaridial
|
121362-23-0
|
|
|
2-allyloxycarbonylamino-1,6-anhydro-2-deoxyglucopyranose
|
121363-69-7
|
C10H15NO6
|
|
Ethanone, 1-(3,3,5-trimethyl-1-cyclopenten-1-yl)- (9CI)
|
121366-39-0
|
C10H16O
|
|
(S)-(+)-DIMETHINDENE MALEATE
|
121367-05-3
|
C20H24N2
|
|
Bernardioside A
|
121368-52-3
|
C36H58O11
|
|
Ethyl perfluoro-2,5,8,11,14,17-hexamethyl-3,6,9,12,15,18-hexaoxaeicosanoate
|
121368-60-3
|
C23H5F41O8
|
|
N-(3-iodo-4-azidophenylpropionamido)cysteinyl-5-(2'-thiopyridyl)cysteine-coenzyme A
|
121368-75-0
|
C33H47IN11O19P3S2
|
|
beta-cyclodextrin tetradecasulfate
|
121369-51-5
|
C42H70O77S14
|
|
METFORMIN
|
121369-64-0
|
C4H11N5
|
|
4-(9H-Purin-6-yl)-piperazine-1-carboxylic acid tert-butyl ester
|
121370-56-7
|
C14H20N6O2
|
|
Piperazine-1,4-dicarboxylic acid benzyl ester tert-butyl ester
|
121370-60-3
|
C17H24N2O4
|
|
1-Piperazinecarboxylic acid, 4-(3H-iMidazo[4,5-c]pyridin-4-yl)-, 1,1-diMethylethyl ester
|
121370-68-1
|
C15H21N5O2
|
|
1,4-Benzenedicarboxylic acid, polymer with hexanedioic acid, 1,1'-oxybis[2-propanol] and 1,2-propanediol
|
121372-50-7
|
C23H38O13
|
|
2-Propenoic acid, 2-methyl-, methyl ester, telomer with butyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, 2-(methylamino)ethanol and oxiranylmethyl 2-methyl-2-propenoate, (±)-2-hydroxypropanoate (salt) (S)-2-hydroxypropanoate (salt)
|
121372-53-0
|
|
|
2-Propenoic acid, telomer with ethenylbenzene, ethyl 2-propenoate, 2-hydroxyethyl 2-propenoate and 2-mercaptoethanol
|
121372-54-1
|
C23H34O8S
|
|
Bis(2-(trimethylsilyl)ethyl) diisopropylphosphoramidite
|
121373-20-4
|
C16H40NO2PSi2
|
|
D-Proline, 3-methoxy-, methyl ester, (3S)-rel- (9CI)
|
121373-41-9
|
C7H13NO3
|
|
D-Proline, 3-methoxy-, methyl ester, (3R)-rel- (9CI)
|
121373-42-0
|
C7H13NO3
|
|
2-Propanone, 1-(2-oxazolidinylidene)-, (E)- (9CI)
|
121373-71-5
|
C6H9NO2
|
|
Butanedioic acid, (dimethoxyphosphinyl)-, dimethyl ester, reaction products with lauryl alc. and polyethylene glycol
|
121375-86-8
|
(C12H26O.C8H15O7P.(C2H4O)nH2O)x
|
|
Urea, polymer with benzenamine, formaldehyde and 1,3,5-triazine-2,4,6-triamine, bisulfited
|
121375-94-8
|
C11H19N9O2
|
|
ENDOTHELIN (16-21)
|
121377-67-1
|
C39H57N9O9
|
|
3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4H-1,2,4-TRIAZOL-4-AMINE HYDROCHLORIDE
|
121378-82-3
|
C7H11ClN6
|
|
ANGIOTENSIN II ANTIPEPTIDE
|
121379-63-3
|
C42H62N10O12
|
|
2H-Isoxazolo[5,4-b]azepin-3(4H)-one,5,6,7,8-tetrahydro-(9CI)
|
121379-66-6
|
C7H10N2O2
|
|
|
(N-acetylneuraminosyl-(2--8)-N-glycolylneuraminic acid)gangliotetraosylceramide
|
121382-26-1
|
|
|
|
Acid black 227
|
121382-28-3
|
|
|
7-Oxabicyclo[4.1.0]heptane, 4-ethynyl-1-methyl-, [1S-(1alpha,4beta,6alpha)]- (9CI)
|
121383-74-2
|
C9H12O
|
|
4-(carboxymethylthio)betamethasone
|
121383-83-3
|
C24H31FO7S
|
|
5-HYDRAZINO-ISOPHTHALIC ACID
|
121385-69-1
|
C8H8N2O4
|
|
1-trimethylsilyl-1-propanol
|
121386-64-9
|
|
|
1,3-Dioxolane, 2-(1,1,2-trimethyl-2-propenyl)- (9CI)
|
121389-16-0
|
C9H16O2
|
|
S-butyl 4-bromothiophenol
|
121392-35-6
|
C10H13BrS
|
|
6-BROMO-2,3-DIMETHYLIMIDAZO[1,2-A]PYRIDINE
|
121394-38-5
|
C9H9BrN2
|
|
CODEINE IMP C
|
121395-47-9
|
C36H40N2O6
|
|
|
plastin
|
121396-96-1
|
|
|
Benzoyl chloride, 4-(dimethylsilyl)- (9CI)
|
121398-92-3
|
C9H11ClOSi
|
|
2,3,7,8,12,13,17,18-Octafluoro-5,10,15,20-tetrakis(pentafluorophenyl)porphyrin
|
121399-88-0
|
C44H2F28N4
|
|
4-iodo-3-methoxybenzaldehyde
|
121404-83-9
|
C8H7IO2
|
|
Morpholine, 4-(chlorodifluoroacetyl)- (9CI)
|
121412-23-5
|
C6H8ClF2NO2
|
|
Piperazine, 1-(chlorodifluoroacetyl)- (9CI)
|
121412-25-7
|
C6H9ClF2N2O
|
|
Piperazine, 1-(2,2-difluoroacetyl)-4-methyl- (9CI)
|
121412-30-4
|
C7H12F2N2O
|
|
2-Butanone, 1-chloro-1,1-difluoro-3-methyl-
|
121412-64-4
|
C5H7ClF2O
|
|
CEFPROZIL (Z)-ISOMER (200 MG)H0E054927UG/MG(AI)
|
121412-77-9
|
C18H19N3O5S
|
|
Cyclopropanecarboxaldehyde, 2-methyl-3-phenyl-, (1alpha,2alpha,3beta)- (9CI)
|
121422-18-2
|
C11H12O
|
|
(+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid
|
121424-36-0
|
C8H12O2
|
|
EMaMectin B1b
|
121424-52-0
|
C48H73NO13
|
|
Boc-DL-histidine
|
121428-29-3
|
C11H17N3O4
|
|
Serine, 2-methyl-N-(1-oxopentyl)-
|
121428-31-7
|
C9H17NO4
|
|
L-Ornithine, N5,N5-dimethyl- (9CI)
|
121428-46-4
|
C7H16N2O2
|
|
glycyl-alanyl-valine
|
121428-48-6
|
C10H19N3O4
|
|
N-(4-Methoxybenzoyl)-beta-alanine
|
121428-49-7
|
C11H13NO4
|
|
Butanoic acid, 2-[(1-oxohexyl)amino]-
|
121428-72-6
|
C10H19NO3
|
|
Butanoic acid, 2-[(ethoxycarbonyl)amino]-
|
121428-73-7
|
C7H13NO4
|
|
N-cyclohexanoylleucine
|
121428-84-0
|
C13H23NO3
|
|
N-Isopropyl-3-fluoroaniline
|
121431-27-4
|
C9H12FN
|
|
1H-1,2,4-Triazole,1-(cyclopropylcarbonyl)-(9CI)
|
121432-05-1
|
C6H7N3O
|
|
Methyl 5-oxazolecarboxylate
|
121432-12-0
|
C5H5NO3
|
|
AC-HIS-TRP-ALA-VAL-GLY-HIS-LEU-NH2
|
121432-21-1
|
C41H57N13O8
|
|
Benzoic acid, 4-methoxy-, 3-hexenyl ester, (Z)-
|
121432-33-5
|
C6H14N2O
|
|
4-phenyl-6,7-dihydrothieno<2,3-c>pyridine
|
121433-80-5
|
C13H11NS
|
|
5-Cyano-1-p-tolyl-1H-pyrazole-3-carboxylic acid ethyl ester
|
121434-51-3
|
C14H13N3O2
|
|
2-CHLORO-3,5-DIFLUORO-4-(TRIFLUOROMETHYL)PHENYL HYDRAZINE
|
121435-36-7
|
C7H4ClF5N2
|
|
Benzeneethanimidoyl chloride, 4-ethyl-N-hydroxy-alpha-oxo- (9CI)
|
121435-92-5
|
C10H10ClNO2
|
|
2,3-Pentanedione, 4-methyl-, 3-oxime, (Z)- (9CI)
|
121436-02-0
|
C6H11NO2
|